More evidence on risks of antipsychotics in adults

Published: April, 2009

Commentaries provide advice about putting the results in perspective.

Two studies provide evidence that second-generation antipsychotics increase risk of death, especially when the drugs are prescribed at high doses. Another report, on the third phase of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia study, found unexpected increases in blood sugar levels among patients taking aripiprazole (Abilify).

To continue reading this article, you must log in.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise

New subscriptions to Harvard Health Online are temporarily unavailable. Click the button below to learn about our other subscription offers.

Learn More »